Act No 161 / 2021 Coll.
Act amending Act No. 592 / 1992 Coll., on Insurance against Public Health Insurance, as amended, and certain other laws
Valid
Effective from 10.04.2021
Text versions:
10.04.2021
09.04.2021
161
THE LAW
of 31 March 2021
amending Act No. 592 / 1992 Coll., on Insurance against Public Health Insurance, as amended, and certain other laws
Parliament has decided on this law of the Czech Republic:
Amendment to the Public Health Insurance Insurance Act
Act No. 10 / 1993 Coll., Act No. 15 / 1993 Coll., Act No. 53 / 2004 Coll., Act No. 127 / 1998 Coll., Act No. 49 / 2002 Coll., Act No. 176 / 2002 Coll., Act No. 424 / 2003 Coll., Act No. 492 / 2000 Coll., Act No. 138 / 2001 Coll., Act No. 49 / 2002 Coll.
The deadline for the submission of the summary referred to in Article 24 (2) provided for in Article 24 (2) shall not apply to the submission of the summary for 2020. The list referred to in Article 24 (2) for 2020 shall be submitted by the self-employed person to all health insurance undertakings for which he was insured during that period by 2 August 2021 at the latest. '
Amendment of the Act on the General Health Insurance Company of the Czech Republic
Act No. 551 / 1991 Coll., on the General Health Insurance Company of the Czech Republic, as amended by Act No. 592 / 1992 Coll., Act No. 10 / 1993 Coll., Act No. 60 / 1995 Coll., Act No. 149 / 1996 Coll., Act No. 48 / 1997 Coll., Act No. 305 / 1997 Coll., Act No. 49 / 2002 Coll., Act No. 420 / 2003 Coll., Act No. 455 / 2003 Coll., Act No. 298 / 2004 Coll., Act No. 117 / 2006 Coll., Act No. 261 / 2007 Coll., Act No. 266 / 2007 Coll., Act No. 296 / 2007 Coll., Act No. 455 / 2003 Coll., Act No. 438 / 2004 Coll.
1. in Article 7 (1) (a), "3" is replaced by "4."
2. In Article 7, the following paragraph 3 is inserted after paragraph 2:
"(3) For the purpose of promoting the testing of workers and self-employed persons for the presence of SARS CoV-2 antigen by means of an in vitro diagnostic medical device for self-testing or by means of an in vitro diagnostic medical device for which the Ministry of Health has been authorised under the Law governing in vitro diagnostic medical devices by a lay person, an insurance undertaking in excess of the resources referred to in paragraph 2, fourth sentence, shall use the funds of the basic fund as an additional source of the prevention fund. In such cases, the allocation of funds from the basic fund to the prevention fund shall be made by the insurance undertaking within 60 days of the end of the calendar month, at the level of the funds spent in that calendar month from the prevention fund to support the testing referred to in the first sentence. The temporary secondment of staff of the Agency to work and other persons who, on the basis of a legal relationship other than the employment relationship, carry out work or similar activity at the employer's place of work, shall also be regarded as staff under the first sentence. ';
Paragraphs 3 to 6 shall be renumbered paragraphs 4 to 7.
3. in Article 23b (1) (c), "5" is replaced by "6."
Amendment of the Act on departmental, branch, corporate and other health insurance companies
Act No. 280 / 1992 Coll., on departmental, branch, corporate and other health insurance companies, as amended by Act No. 10 / 1993 Coll., Act No. 15 / 1993 Coll., Act No. 60 / 1995 Coll., Act No. 149 / 1996 Coll., Act No. 60 / 2014 Coll., Act No. 48 / 1997 Coll., Act No. 93 / 1998 Coll., Act No. 127 / 1998 Coll., Act No. 225 / 1999 Coll., Act No. 220 / 2000 Coll., Act No. 49 / 2002 Coll., Act No. 420 / 2003 Coll.
1. In Article 19, the following paragraph 2 is inserted after paragraph 1:
"(2) For the purpose of supporting the testing of workers and self-employed persons for the presence of SARS CoV-2 antigen by means of an in vitro diagnostic medical device for self-testing or by means of an in vitro diagnostic medical device for which the Ministry of Health has been authorised under the Law governing in vitro diagnostic medical devices by a lay person, an employee insurance company in excess of the resources referred to in Section 16 (4), fourth sentence, as an additional source of the preventive fund, shall use the funds of the basic fund. In such cases, the allocation of funds from the basic fund to the prevention fund shall be made by the employee insurance undertaking within 60 days of the end of the calendar month, at the level of the funds spent by the prevention fund during that calendar month to support the testing referred to in the first sentence. The temporary secondment of staff of the Agency to work and other persons who, on the basis of a legal relationship other than the employment relationship, carry out work or similar activity at the employer's place of work, shall also be regarded as staff under the first sentence. ';
Paragraph 2 shall become paragraph 3.
2. in Paragraph 22e (1) (e), "2" is replaced by "3."
EFFECTIVE
This Act shall take effect on the day following its publication.
Vondracek v. r.
Zeman v. r.
Babiš v. r.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Act No. 161 / 2021 Coll., amending Act No. 592 / 1992 Coll., on Insurance against Public Health Insurance, as amended, and certain other laws |
|---|---|
| Regulation Type | - |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 09.04.2021 |
|---|---|
| Effective from | 10.04.2021 |
| Effective until | - |
| Status | Valid |
The regulation text is for informational purposes only.
Comments 0